FoxBio's Corporate Minority - II Round

FoxBio raised a round of funding on July 25, 2018. Investors include Antoxerene.

FoxBio, created by Antoxerene and Juvenescence, will develop Antoxerene's collection of small molecules that target senescent cells - cells that cause diseases, such as cancer, as people age.…

Articles about FoxBio's Corporate Minority - II Round: